Ferring Pharmaceuticals, a Swiss biopharma firm, focuses on worker well-being and DEI. Purvi Tailor, head of human resources in its US business, is on BI's Workforce Innovation board. This article is ...
Whether happening in public or private, biopharma M&A is fiercer than ever. Experts point to patent pressures, herd mentality ...
On Thursday, Amphastar Pharmaceuticals Inc. (NASDAQ:AMPH) reported fourth-quarter adjusted EPS of 92 cents, up from 88 cents a year ago, but missing the consensus of 94 cents. Amphastar is a ...
The pharmaceutical industry is engaging in a flurry of biotech deals and shifting clinical trials to China. It does so at a time when the U.S. is distancing from China.
On Monday, BridgeBio Pharma, Inc. (NASDAQ:BBIO) presented initial outcomes from the ATTRibute-CM open-label extension (OLE) study of acoramidis in ATTR-CM at the American Heart Association Scientific ...
Forecasts project rare disease drugs will exceed $400B in 2032 revenues (~21% of prescriptions), reinforcing their role as a core growth engine despite policy and competitive volatility. IRA revisions ...
The OLE study involves 330 participants who completed the 30-month ATTRibute-CM Phase 3 study. Key initial results from the OLE study show that continuous treatment with acoramidis led to: The OLE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results